{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:25:51Z","timestamp":1791390351067,"version":"4.3.3"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T00:00:00Z","timestamp":1699660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007737","name":"St. Jude Children\u2019s Research Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA157838"],"award-info":[{"award-number":["R01 CA157838"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"G. Armstrong, Principal Investigator","award":["U01 CA195547"],"award-info":[{"award-number":["U01 CA195547"]}]},{"name":"Cancer Center Support","award":["P30 CA21765"],"award-info":[{"award-number":["P30 CA21765"]}]},{"DOI":"10.13039\/100012524","name":"American Lebanese-Syrian Associated Charities","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Childhood cancer survivors have increased risk of dyslipidemia and atherosclerotic cardiovascular disease (CVD). The aim of this study was to evaluate the prevalence and associated cardiovascular risks of specific lipid abnormalities among childhood cancer survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Comprehensive lipid panel measurements were obtained from 4115 5-year survivors, with 3406 (mean age at evaluation = 35.2\u2009years, SD = 10.4 years) not having previous dyslipidemia diagnosis, as well as 624 age, sex, and race and ethnicity matched community controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Previously undiagnosed dyslipidemia with abnormal low-density lipoprotein (LDL) cholesterol (&amp;gt;160\u2009mg\/dL), non\u2013high density lipoprotein (HDL) cholesterol (&amp;gt;190\u2009mg\/dL), HDL cholesterol (&amp;lt;40\u2009mg\/dL for men, &amp;lt;50\u2009mg\/dL for women), and triglycerides (&amp;gt;150\u2009mg\/dL) were identified in 4%, 6%, 30%, and 17%, respectively. Survivors without previous dyslipidemia diagnosis had higher LDL cholesterol and non-HDL cholesterol and lower HDL cholesterol than community controls. Cranial radiotherapy (relative risk [RR] = 2.2, 95% confidence interval [CI] = 1.6 to 3.0 for non-HDL cholesterol) and total body irradiation for hematopoietic cell transplantation (RR = 6.7, 95% CI = 3.5 to 13.0 for non-HDL cholesterol; RR = 9.9, 95% CI = 6.0 to 16.3 for triglycerides) were associated with greater risk of dyslipidemia. Diagnoses of low HDL cholesterol (hazard ratio [HR] = 2.9, 95% CI = 1.8 to 4.7) and elevated triglycerides (HR = 3.1, 95% CI = 1.9 to 5.1) were associated with increased risk for myocardial infarction, and diagnoses of high LDL cholesterol (HR = 2.2, 95% CI = 1.3 to 3.7), high non-HDL cholesterol (HR = 2.2, 95% CI = 1.3 to 3.7), low HDL cholesterol (HR = 3.9, 95% CI = 2.8 to 5.4), and elevated triglycerides (HR = 3.8, 95% CI = 2.7 to 5.5) were associated with increased risk for cardiomyopathy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Previously undiagnosed dyslipidemia among childhood cancer survivors was associated with increased risk for myocardial infarction and cardiomyopathy. Comprehensive dyslipidemia evaluation and treatment are needed to reduce cardiovascular morbidity in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jnci\/djad222","type":"journal-article","created":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T16:19:54Z","timestamp":1699805994000},"page":"408-420","source":"Crossref","is-referenced-by-count":14,"title":["Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report"],"prefix":"10.1093","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8351-6376","authenticated-orcid":false,"given":"Jason F","family":"Goldberg","sequence":"first","affiliation":[{"name":"Department of Heart Failure and Transplantation, Inova Heart and Vascular Institute , Falls Church, VA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geehong","family":"Hyun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-1507","authenticated-orcid":false,"given":"Kirsten K","family":"Ness","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B","family":"Dixon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Towbin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Tennessee Health Science Center , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-1445","authenticated-orcid":false,"given":"Isaac B","family":"Rhea","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Tennessee Health Science Center , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J","family":"Ehrhardt","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deo Kumar","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-9115","authenticated-orcid":false,"given":"Daniel A","family":"Mulrooney","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M","family":"Hudson","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie L","family":"Robison","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Jefferies","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Tennessee Health Science Center , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Texas Southwestern , Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Cancer Control, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"},{"name":"Department of Oncology, St. Jude Children\u2019s Research Hospital , Memphis, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,11]]},"reference":[{"issue":"1","key":"2024030715232201600_djad222-B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: Life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2024030715232201600_djad222-B2","author":"National Cancer Institute"},{"issue":"29","key":"2024030715232201600_djad222-B3","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/jco.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"issue":"14","key":"2024030715232201600_djad222-B4","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/jco.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024030715232201600_djad222-B5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/1055-9965.epi-09-0555","article-title":"Cardiovascular risk factors in adult survivors of pediatric cancer\u2014a report from the childhood cancer survivor study","volume":"19","author":"Meacham","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"2024030715232201600_djad222-B6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/jco.2017.74.8673","article-title":"Prediction of ischemic heart disease and stroke in survivors of childhood cancer","volume":"36","author":"Chow","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"2024030715232201600_djad222-B7","doi-asserted-by":"publisher","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"issue":"15","key":"2024030715232201600_djad222-B8","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study","volume":"169","author":"Meacham","year":"2009","journal-title":"Arch Intern Med"},{"issue":"22","key":"2024030715232201600_djad222-B9","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"2024030715232201600_djad222-B10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.7326\/m15-0424","article-title":"Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: a cross-sectional study","volume":"164","author":"Mulrooney","year":"2016","journal-title":"Ann Intern Med"},{"issue":"25 suppl 2","key":"2024030715232201600_djad222-B11","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"25","key":"2024030715232201600_djad222-B12","doi-asserted-by":"publisher","first-page":"e1046","DOI":"10.1161\/cir.0000000000000624","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"2024030715232201600_djad222-B13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","article-title":"Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity","volume":"5","author":"Feijen","year":"2019","journal-title":"JAMA Oncol"},{"issue":"6","key":"2024030715232201600_djad222-B14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2024030715232201600_djad222-B15","year":"2010"},{"issue":"5","key":"2024030715232201600_djad222-B16","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1055-9965.epi-16-0812","article-title":"Approach for classification and severity grading of long-term and late-onset health events among childhood cancer survivors in the St. Jude Lifetime Cohort","volume":"26","author":"Hudson","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"446","key":"2024030715232201600_djad222-B17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2024030715232201600_djad222-B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10985-014-9313-9","article-title":"Checking Fine and Gray subdistribution hazards model with cumulative sums of residuals","volume":"21","author":"Li","year":"2015","journal-title":"Lifetime Data Anal"},{"issue":"3","key":"2024030715232201600_djad222-B19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","article-title":"Test for additive interaction in proportional hazards models","volume":"17","author":"Li","year":"2007","journal-title":"Ann Epidemiol"},{"issue":"24","key":"2024030715232201600_djad222-B20","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease a special report from the American Heart Association and American College of Cardiology","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol. Published"},{"issue":"7","key":"2024030715232201600_djad222-B21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.annepidem.2007.01.032","article-title":"Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults","volume":"17","author":"Hyre","year":"2007","journal-title":"Ann Epidemiol"},{"issue":"5","key":"2024030715232201600_djad222-B22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1161\/circulationaha.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns","volume":"129","author":"Frank","year":"2014","journal-title":"Circulation"},{"issue":"5","key":"2024030715232201600_djad222-B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/jco.2014.56.1373","article-title":"Individual prediction of heart failure among childhood cancer survivors","volume":"33","author":"Chow","year":"2015","journal-title":"J Clin Oncol"},{"issue":"19","key":"2024030715232201600_djad222-B24","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/jnci\/djn310","article-title":"Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study","volume":"100","author":"Mertens","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"2024030715232201600_djad222-B25","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/nejm199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"2024030715232201600_djad222-B26","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djz108","article-title":"Traditional cardiovascular risk factors and individual prediction of cardiovascular events in childhood cancer survivors","volume":"112","author":"Chen","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"2024030715232201600_djad222-B27","author":"Children\u2019s Oncology Group","year":"2018"},{"issue":"11","key":"2024030715232201600_djad222-B28","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/cir.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"issue":"19","key":"2024030715232201600_djad222-B29","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"2024030715232201600_djad222-B30","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1200\/jco.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J Clin Oncol"},{"issue":"3","key":"2024030715232201600_djad222-B31","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaccao.2020.06.004","article-title":"Comprehensive characterization of the vascular effects of cisplatin-based chemotherapy in patients with testicular cancer","volume":"2","author":"Cameron","year":"2020","journal-title":"JACC CardioOncol"},{"issue":"1","key":"2024030715232201600_djad222-B32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10517-020-04997-1","article-title":"Features of myocardial remodeling and changes in the blood lipid spectrum in experimental doxorubicin-induced cardiomyopathy and atorvastatin administration","volume":"170","author":"Klinnikova","year":"2020","journal-title":"Bull Exp Biol Med"},{"issue":"33","key":"2024030715232201600_djad222-B33","doi-asserted-by":"publisher","first-page":"e21498","DOI":"10.1097\/md.0000000000021498","article-title":"Adjuvant chemotherapy-associated lipid changes in breast cancer patients","volume":"99","author":"He","year":"2020","journal-title":"Medicine (Baltimore)"},{"issue":"10112","key":"2024030715232201600_djad222-B34","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/s0140-6736(17)31610-0","article-title":"The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)","volume":"390","author":"Bhakta","year":"2017","journal-title":"Lancet"},{"key":"2024030715232201600_djad222-B35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009-2107C"},{"issue":"5","key":"2024030715232201600_djad222-B36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/pbc.22875","article-title":"Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study","volume":"56","author":"Hudson","year":"2011","journal-title":"Pediatr Blood Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djad222\/54359511\/djad222.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/3\/408\/56829316\/djad222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/116\/3\/408\/56829316\/djad222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T17:46:44Z","timestamp":1709833604000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/116\/3\/408\/7413180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,11]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,11,11]]},"published-print":{"date-parts":[[2024,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djad222","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,11,11]]}}}